{
    "code": "01011308",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01011308",
    "time": "2022-01-28 03:03:15",
    "許可證字號": "衛署藥製字第011308號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "108\/05\/25",
    "發證\/登錄日期": "65\/12\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00101130802",
    "中文品名": "&quot;國信&quot;貝他松注射液",
    "英文品名": "Betasone Injection &quot;K.S.&quot;",
    "適應症": "關節炎、僂麻質熱、膠原病、過敏性疾患、支氣管氣喘、藥物過敏、血清病等結合織炎、關節周圍炎、痛風、重症皮膚症狀（濕疹、皮膚炎、乾癬等）副腎皮質機能不全",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BETAMETHASONE (SODIUM PHOSPHATE)",
    "限制項目": "01國　產 09委託製造 1R不得製造",
    "申請商名稱": "1101417200  國信藥品股份有限公司",
    "申請商地址": "嘉義市西區新民路115號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804009231",
            "成分名稱": "BETAMETHASONE (SODIUM PHOSPHATE)",
            "含量描述": "(5.27MG) 4",
            "含量": "",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "1413-貝他松-104-12-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01011308&Seq=003&Type=9"
        }
    ]
}